News

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in
An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Nordic Stocks Decline; Sinch Takes Biggest Hit
Stora Enso Oyj Series R (SEK) was the biggest leader, surging 14.6%, and Stora Enso Oyj Series A (SEK) surged 14.3%. Schouw & Co. A/S rounded out the top three leaders on Thursday, with shares gaining ...
Drug Store News6d
Alvotech, Dr. Reddy’s to co-develop Keytruda biosimilar
Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...